1-3 of 3
Robert G. Pearcey, MD
Close
Sort by
Journal Articles

Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Annette E. Hay, MBChB, Beate Klimm, MD, Bingshu E. Chen, PhD, Helen Goergen, Lois E. Shepherd, M.D., Michael Fuchs, MD, Mary Gospodarowicz, MD, Peter Borchmann, MD, Joseph M. Connors, MD, Jana Markova, MD, Michael Crump, MD, FRCPC, Andreas Lohri, MD, Jane N. Winter, MD, Bernd DoĢˆrken, Robert G. Pearcey, MD, Volker Diehl, MD, Sandra J. Horning, M.D., Hans Theodor Eich, MD, Andreas Engert, MD, Ralph M. Meyer, MD
Journal: Blood
Blood (2012) 120 (21): 548.
https://doi.org/10.1182/blood.V120.21.548.548
Published: 2012
Journal Articles

Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6

Ralph M. Meyer, MD, Mary Gospodarowicz, MD, Joseph M. Connors, MD, Robert G Pearcey, MD, Woodrow A Wells, MD, Jane N. Winter, MD, Sandra J. Horning, MD, A. Rashid Dar, MD, Chaim Shustik, MD, Douglas A. Stewart, MD, Michael Crump, MD, FRCPC, Marina S Djurfeldt, MSc, Bingshu E Chen, PhD, Lois E Shepherd, M.D.
Journal: Blood
Blood (2011) 118 (21): 590.
https://doi.org/10.1182/blood.V118.21.590.590
Published: 2011
Journal Articles

Relapse Patterns and Subsequent Outcomes of Patients Treated on the NCIC CTG HD.6 (ECOG JHD06) Randomized Trial Evaluating ABVD Alone in Patients with Limited Stage Hodgkin Lymphoma (HL).

David A. Macdonald, MD, Mary K. Gospodarowicz, MD, Woodrow A. Wells, MD, Robert G. Pearcey, MD, Joseph M. Connors, MD, Jane N. Winter, MD, Sandra J. Horning, MD, Marina S. Djurfeldt, MSc, Keyue Ding, PhD, Lois E. Shepherd, MD, Ralph M. Meyer, MD
Journal: Blood
Blood (2005) 106 (11): 817.
https://doi.org/10.1182/blood.V106.11.817.817
Published: 2005